✅ Model Answer:
• Diagnosis: Abetalipoproteinemia (Bassen-Kornzweig syndrome – MTTP gene mutation).
• Evidence: Very low cholesterol and triglycerides, acanthocytosis, fat-soluble vitamin deficiency (especially vitamin E), steatorrhea, failure to thrive, protruding abdomen. Normal fecal elastase and sweat chloride rule out CF and pancreatic insufficiency.
• Next step: Genetic testing (MTTP gene). Start high-dose vitamin E supplementation (to prevent neurologic degeneration), MCT oil, and fat-soluble vitamins (ADEK). Low-fat diet (with MCT). Multidisciplinary care (neurology, ophthalmology, nutrition).

✅ Model Answer:
• Gene: MTTP (microsomal triglyceride transfer protein) located on chromosome 4q23.
• Inheritance: Autosomal recessive.
• Protein: MTTP is essential for the assembly and secretion of apolipoprotein B-containing lipoproteins (chylomicrons, VLDL, LDL) in the liver and intestine.
• Pathophysiology: MTTP deficiency → impaired assembly of chylomicrons and VLDL → failure to transport dietary fats (triglycerides, cholesterol, fat-soluble vitamins) → fat malabsorption, low serum lipids, and fat-soluble vitamin deficiencies.
• Prevalence: Very rare (<1 in 1,000,000).

✅ Model Answer:
• GI features:
- Chronic diarrhea, steatorrhea: Bulky, foul-smelling, greasy stools (fat malabsorption).
- Failure to thrive.
- Protruding abdomen.
- Abdominal distension.
• Neurologic (due to vitamin E deficiency):
- Ataxia: Progressive spinocerebellar degeneration.
- Peripheral neuropathy: Weakness, sensory loss, areflexia.
- Retinopathy: Pigmentary retinopathy (similar to retinitis pigmentosa).
- Myopathy.
- Dysarthria.
• Hematologic:
- Acanthocytosis: Spiky red blood cells (pathognomonic).
- Anemia (due to vitamin E deficiency and abnormal RBC membranes).
• Other: Ophthalmoplegia, ptosis.

✅ Model Answer:
• Lipid profile:
- Cholesterol: Very low (<50 mg/dL).
- Triglycerides: Very low (<30 mg/dL).
- LDL: Undetectable.
- VLDL: Undetectable.
• Peripheral smear: Acanthocytes (spiculated RBCs).
• Fat-soluble vitamins:
- Vitamin E: Very low (most important).
- Vitamin A, D, K: Low.
• Stool fat: Steatorrhea (elevated fecal fat).
• Genetic testing: MTTP gene sequencing (confirmatory).
• Rule out other causes: Normal fecal elastase (excludes CF/pancreatic insufficiency), normal sweat chloride, negative anti-tTG IgA.

✅ Model Answer:
• Dietary management:
- Low-fat diet: Reduces steatorrhea.
- Medium-chain triglycerides (MCT) oil: MCT is absorbed directly into the portal system (bypassing lymphatic/chylomicron pathway), providing calories and essential fatty acids.
- MCT-based formula: For children who cannot tolerate oral diet.
• Fat-soluble vitamin supplementation:
- High-dose vitamin E: 100-400 IU/kg/day (to prevent neurologic degeneration).
- Vitamin A: 10,000-25,000 IU/day (monitor for toxicity).
- Vitamin D: 1,000-2,000 IU/day.
- Vitamin K: 5-10 mg/day (if bleeding risk).
• Monitoring:
- Neurologic exam: Regular assessments for ataxia, neuropathy.
- Ophthalmology: Monitor for retinopathy.
- Growth.
- Vitamin levels.
• Multidisciplinary care: Gastroenterologist, neurologist, ophthalmologist, dietitian.

✅ Model Answer:
• Neurologic:
- Progressive spinocerebellar degeneration: Ataxia, dysarthria, intention tremor.
- Peripheral neuropathy: Weakness, sensory loss, areflexia.
- Retinopathy: Progressive vision loss, night blindness.
- Ophthalmoplegia, ptosis.
- Dementia (in severe cases).
• Hematologic:
- Anemia: Hemolytic anemia (due to acanthocytosis).
- Thrombocytopenia.
• GI:
- Steatorrhea.
- Failure to thrive.
- Malabsorption.
• Other:
- Hepatic steatosis.
- Osteoporosis (vitamin D deficiency).
- Death: Usually from neurologic complications or cardiac issues (rare).

✅ Model Answer:
• Prognosis:
- Guarded – depends on early diagnosis and treatment.
- With high-dose vitamin E: Neurologic progression can be slowed or halted.
- Without treatment: Severe neurologic degeneration by adolescence.
- Life expectancy: Reduced, but improved with early vitamin E supplementation.
- Quality of life: Can be good with multidisciplinary care.
• Long-term follow-up:
- Monitor neurologic function: Regular exams, MRI (if indicated).
- Monitor ophthalmologic status: Annual eye exams.
- Monitor vitamin levels: Vitamin E, A, D, K.
- Monitor growth and nutrition.
- Genetic counseling: Autosomal recessive (25% recurrence risk).
- Screen for complications: Anemia, hepatic steatosis.

✅ Model Answer:
• Acanthocytes: Spiculated or spur-shaped red blood cells with irregular projections.
• Role:
- Pathognomonic: Acanthocytosis is a hallmark of abetalipoproteinemia.
- Mechanism: Abnormal RBC membrane lipid composition (due to low cholesterol and vitamin E) → altered membrane fluidity → acanthocyte formation.
• Diagnostic significance:
- Key finding: Acanthocytes on peripheral smear, combined with very low cholesterol and triglycerides, strongly suggests abetalipoproteinemia.
- Differentiates: From other causes of steatorrhea and failure to thrive.
• Other conditions with acanthocytes: Severe liver disease, neuroacanthocytosis, McLeod syndrome.
• Monitoring: Acanthocytes may persist despite treatment; not useful for monitoring response.